Neogenomics, Inc. · NASDAQ:NEO
BlackRock, Inc. reported a 15.60% stake in Neogenomics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 30, 2026
BlackRock, Inc. reported a 15.60% stake in Neogenomics, Inc., 20,358,331 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G/A).
- Stake
- 15.60%
- Shares
- 20,358,331
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 15.60% | 20,358,331 |
Source
Related
- Neogenomics, Inc.
- BlackRock, Inc.
- Neogenomics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Form 4 · Stone Warren · Oct 5, 2026
- Form 4 · Olivo Alicia C · Sep 3, 2026
- Form 4 · Stone Warren · Aug 25, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Aug 14, 2026
- Form 4 · Aunan Greg D · Aug 6, 2026